RESUMO
OBJECTIVE: Cerebrospinal fluid (CSF) dynamics and long-term shunt survival of the Strata CSF shunt were evaluated in patients with idiopathic normal pressure hydrocephalus (INPH). SUBJECTS AND METHODS: Seventy-two patients with INPH received a Strata valve. A CSF infusion test, neuroimaging and video recording of gait were performed at baseline and at 6 months (n = 68) after surgery. Long-term shunt survivals were obtained from patient records. RESULTS: The shunt survival at 1 year was 94% and at 3 years 92.5%. Forty-nine patients (72%) had an improved gait. Two patients were improved despite non-functioning shunts, indicating a possible placebo response. Nineteen patients were not improved at the 6-month follow-up. The shunt tests revealed a functioning shunt in 12; thus, unnecessary shunt revisions could be avoided. Seventeen patients showed a siphoning effect. Shunt revisions were made in six patients. Eight hygromas/subdural hematomas were found. CONCLUSIONS: The long-term survival of the Strata valves was good, and a concern of complications is not a reason to exclude elderly with INPH from shunt surgery. Studies are needed to evaluate pros and cons of the anti-siphon device. Using a CSF shunt test, unnecessary shunt revisions may be avoided.
Assuntos
Pressão do Líquido Cefalorraquidiano/fisiologia , Derivações do Líquido Cefalorraquidiano/instrumentação , Derivações do Líquido Cefalorraquidiano/métodos , Hidrocefalia de Pressão Normal , Dinâmica não Linear , Idoso , Idoso de 80 Anos ou mais , Ventrículos Cerebrais/patologia , Feminino , Humanos , Hidrocefalia de Pressão Normal/líquido cefalorraquidiano , Hidrocefalia de Pressão Normal/mortalidade , Hidrocefalia de Pressão Normal/cirurgia , Hidrodinâmica , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Estudos Retrospectivos , Sobrevida , Fatores de TempoRESUMO
In a deteriorating shunted patient with hydrocephalus, an investigation of shunt function is often performed to distinguish a dysfunctioning shunt from an aggravated condition of the disease. The paper illustrates how a lumbar cerebrospinal fluid (CSF) infusion method can be used to evaluate post-operative deterioration in a shunted patient in order to give the physician valuable support in the shunt revision decision. A 77-year-old man with hydrocephalus was treated operatively by the insertion of a CSF shunt. Owing to shunt failure, the shunt was revised twice during a 5 year period. Using a computerised infusion technique method, with two needles placed in the lumbar subarachnoid space, the CSF dynamic system was determined pre- and post-operatively with the functioning as well as the dysfunctioning shunts. The data were verified with a bench-test of the extirpated CSF shunt. There was a significant difference in conductance G between CSF systems with an open shunt and CSF systems with no shunt or an occluded shunt (deltaG= 38 mm3 s(-1) kPa(-1), p = 0.014, n= 7, ANOVA). CSF dynamics investigations, with and without a shunt, can give valuable clinical support in the management of a deteriorating hydrocephalus patient. With further development of the lumbar infusion method moving towards easy-to-use equipment, there is potential for widespread clinical use.
Assuntos
Derivações do Líquido Cefalorraquidiano , Demência/diagnóstico , Hidrocefalia/cirurgia , Idoso , Líquido Cefalorraquidiano/metabolismo , Diagnóstico Diferencial , Falha de Equipamento , Humanos , Pressão Intracraniana , MasculinoRESUMO
OBJECTIVES: Little is known about the long-term impact of a CSF shunt on the human CSF hydrodynamic system. In patients with communicating hydrocephalus, patency of the shunt system is not regularly assessed. In order to reveal postoperative changes in the CSF hydrodynamic system, we prospectively investigated the features of the system in shunted patients with idiopathic adult hydrocephalus syndrome (IAHS) over a 3-year period. MATERIAL AND METHODS: Thirty-two patients with IAHS were studied at baseline and at 3, 9, 18 and 36 months postoperatively. All patients were operated on with a Hakim standard valve system and a ventriculo-peritoneal approach. At each visit, the patients were investigated with computed tomography/magnetic resonance imaging, video recording of gait and a lumbar constant pressure infusion method. Six brand-new Hakim valves were investigated in a bench test, and these results were compared with the in vivo results. RESULTS: After shunt insertion, the CSF outflow resistance was significantly decreased (13.6 vs 3.8 mmHg/ml/min). The mean outflow resistance of the six in vitro tested valves corresponded to the postoperative values. The variation in resistance in the functioning shunts at different postoperative investigations was negligible. The mean intracranial pressure in the supine position was 13.8 mmHg at the baseline and 14.3, 14.5, 14.8 and 15.7 mmHg at the follow-up visits, respectively. Postoperatively, the CSF pressure after sitting for 10 min (i.e. 'siphoning effect') decreased significantly (mean decrease -5.3, -5.4, -4.7 and -5.3 mmHg at each visit, respectively). Shunt-related complications occurred in seven patients (underdrainage four, overdrainage three). Despite a functioning shunt, eight patients never improved and another nine patients first improved but later deteriorated. CONCLUSIONS: The CSF outflow resistance is much decreased postoperatively and does not alter over time in patients with functioning shunts. We consider CSF outflow resistance to be a reliable indicator of shunt function and of fundamental importance to distinguish a dysfunctioning shunt from an aggravation of the primary condition in patients with communicating hydrocephalus. The unaltered intracranial pressure together with the in vitro model results, suggests that the intra-abdominal pressure might be a major determinant of the postoperative intracranial pressure.
Assuntos
Pressão do Líquido Cefalorraquidiano/fisiologia , Derivações do Líquido Cefalorraquidiano/estatística & dados numéricos , Líquido Cefalorraquidiano/fisiologia , Hidrocefalia/cirurgia , Procedimentos Neurocirúrgicos/estatística & dados numéricos , Idoso , Derivações do Líquido Cefalorraquidiano/efeitos adversos , Derivações do Líquido Cefalorraquidiano/normas , Feminino , Seguimentos , Humanos , Hidrocefalia/fisiopatologia , Pressão Intracraniana/fisiologia , Ventrículos Laterais/fisiopatologia , Ventrículos Laterais/cirurgia , Masculino , Procedimentos Neurocirúrgicos/efeitos adversos , Procedimentos Neurocirúrgicos/instrumentação , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/fisiopatologia , Valor Preditivo dos Testes , Estudos Prospectivos , Instrumentos Cirúrgicos/efeitos adversos , Instrumentos Cirúrgicos/estatística & dados numéricos , Resultado do TratamentoRESUMO
OBJECTIVES: The opening pressure and the resistance of a CSF shunt are essential for clinical use in order to set the proper opening pressure and to determine the shunt function in vivo. We find it of vital importance to validate and supplement the product description given by the manufacturer. The in vitro properties of a newly introduced, adjustable differential pressure valve with a siphon-preventing device (Strata valve) was compared with its predecessor (Delta valve). METHODS: An automated, computerized experimental set-up based on regulation of pressure, built into an incubator at 37 degrees C, was used. Opening pressure, resistance and siphon preventing properties were determined. Six brand-new shunts of each type with catheters were tested. The Delta valves were at a performance level of 1.5. RESULTS: The hydrodynamic properties of the Strata and Delta valves were similar. The anti-siphoning device was functioning for all valves. The estimated mean resistance for Delta and Strata shunts was 2.6 +/- 0.4 and 2.2 +/- 1.0 mmHg/ml/min, respectively. The mean opening pressure for the five performance levels of the Strata shunt are: 3.3, 5.1, 7.7, 10.7 and 13.1 mmHg. There may however, be considerable variations between the shunts. CONCLUSIONS: The Strata shunt is a properly working adjustable valve with anti-siphoning device that showed good reproducibility concerning opening pressure and resistance. At performance level 1.5, the new Strata shunt was similar to its predecessor concerning opening pressure and resistance. The given values of the different opening pressures and resistance could be used for in vivo testing of the valve function with a standard lumbar CSF infusion test.
Assuntos
Pressão do Líquido Cefalorraquidiano/fisiologia , Derivações do Líquido Cefalorraquidiano/instrumentação , Hidrocefalia/fisiopatologia , Hidrocefalia/cirurgia , Teste de Materiais , Padrões de Prática Médica , Desenho de Equipamento , Humanos , Técnicas In Vitro , Modelos Neurológicos , Reprodutibilidade dos Testes , ReologiaRESUMO
OBJECT: Few studies have been performed to investigate the cerebrospinal fluid (CSF) hydrodynamic profile in patients with idiopathic adult hydrocephalus syndrome (IAHS) before and after shunt implantation. The authors compared the in vivo CSF hydrodynamic properties, including the degree of gravity-induced CSF flow, of a shunt with an antisiphon device with a standard shunt. METHODS: Twelve patients with IAHS underwent insertion of shunts with Delta valves. Clinical testing, magnetic resonance imaging, and CSF hydrodynamic investigations were conducted with intracranial pressure (ICP), gravity effect, and pressure-flow curve of the shunt estimated at baseline and at 3 and 12 months postoperatively. No shunt was revised. Despite postoperative clinical improvement in all patients who received Delta valves, the mean ICP was only moderately reduced (mean decrease at 3 months 0.3 kPa [p = 0.02], at 12 months 0.2 kPa [not significant]). Patients with the greatest increase in ICP preoperatively had the most pronounced decrease postoperatively. The hydrostatic effect of the Delta valves was significantly lower than with the Hakim shunts (0.1-0.2 kPa compared with 0.6 kPa). The increased conductance (that is, lowered resistance) was up to 14 times higher with the Delta valves compared with preoperative levels. CONCLUSIONS: The function of a CSF shunt may be more complicated than previously thought; the subcutaneous pressure acting on the antisiphon device can modify the shunt characteristics. A compensatory increase in CSF production may counteract the increased outflow through the shunt. The improved CSF outflow conductance may increase the intracranial compliance and thereby dampen a pathological ICP waveform.
Assuntos
Derivações do Líquido Cefalorraquidiano/instrumentação , Hidrocefalia/fisiopatologia , Hidrocefalia/cirurgia , Idoso , Líquido Cefalorraquidiano/fisiologia , Derivações do Líquido Cefalorraquidiano/métodos , Cognição , Feminino , Seguimentos , Marcha , Humanos , Hidrocefalia/reabilitação , Estudos Longitudinais , Masculino , Recuperação de Função Fisiológica , Resultado do TratamentoRESUMO
Sodium valproate enteric-coated tablets were used in this double-blind, randomized, cross-over study of 16 patients with juvenile myoclonic epilepsy comparing 1000 mg and 2000 mg VPA daily in b.i.d. administration with 6 months of observation on each dose. Myoclonic, absence, and generalized tonic-clonic seizures were registered separately. Subjective side-effects were monitored, and a computerized neuropsychologic test battery was performed on each dose. There was no significant difference in seizure frequency between the two doses. Only 25% of the patients were seizure free throughout the study despite concentrations well within the normally proposed therapeutic range for VPA. During the higher dose, 37.5% of the patients had an improved seizure control, but 25% of the patients had an increase in seizure frequency compared to the lower dose. However, there was no correlation between VPA concentrations and subjective side-effects or neuropsychologic test results. Our observations point out the possibility that the common strategy of increasing plasma levels in difficult-to-treat patients until side effects occur should perhaps be reconsidered, but this suggestion needs further confirmation.
Assuntos
Anticonvulsivantes/uso terapêutico , Epilepsias Mioclônicas/tratamento farmacológico , Ácido Valproico/uso terapêutico , Adolescente , Adulto , Anticonvulsivantes/efeitos adversos , Anticonvulsivantes/sangue , Área Sob a Curva , Intervalo Livre de Doença , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Convulsões/prevenção & controle , Fases do Sono/efeitos dos fármacos , Resultado do Tratamento , Ácido Valproico/efeitos adversos , Ácido Valproico/sangue , Aumento de Peso/efeitos dos fármacosRESUMO
Two different doses of sodium valproate (VPA), 500 mg b.i.d. and 1,000 mg b.i.d. as enteric-coated tablets, were used in this randomized, double-blind, cross-over monotherapy study of 16 patients with juvenile myoclonic epilepsy. Observation time was 6 months on each dose and included admittance for a 12-h serum concentration-time curve. There was a nonlinear relation between dose and concentration, with a negative deviation from the linear relation for total concentration and a positive deviation for the unbound fraction. Clearance for total concentration increased during high-dose treatment, but intrinsic clearance did not differ between doses. We measured the variation of repeated total and unbound VPA concentrations in up to 6 monthly samples on each dose. The coefficient of variation was 20.7% for total and 29.9% for unbound concentration on the lower dose, and 16.5% for total and 28.5% for unbound concentration on the higher dose. This difference between doses is not statistically significant. There was good correlation between the concentration taken before morning dose and AUC for one dose interval, especially during high dose, but the morning concentration was not the trough level. We conclude that the pharmacokinetic requirements for therapeutic drug monitoring of VPA are established.
Assuntos
Epilepsias Mioclônicas/tratamento farmacológico , Ácido Valproico/farmacocinética , Adolescente , Adulto , Monitoramento de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
A prospective, controlled and randomized study of 275 patients undergoing major surgery was performed to investigate if postoperative complications were influenced by restrictive use of plasma to replace operative blood loss. All patients were given 6% dextran (Macrodex) for thromboprophylaxis and haemodilution. The "Dextran Group" received equal amounts of 6% dextran and electrolyte solution as substitution for plasma loss. The need for red-cell transfusion (60% suspension in saline-adenine-glucose-mannitol storage medium) averaged 5.8 units in this group and 5.2 in the "Plasma Group". The respective mean totals of infused plasma and dextran were 400 ml and 1,383 ml in the Dextran Group, compared with 1,099 and 619 ml in the Plasma Group. The mean total electrolyte infusion in the first postoperative week was c. 7,500 ml in both groups. Serum albumin decreased considerably in both groups, but significantly more in the Dextran Group. The incidence and pattern of postoperative complications were similar in both groups. When blood loss is up to 50-60% of the total volume, Macrodex can be used in preference to plasma, unless administration of plasma protein is specifically indicated.